Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Clinical Pharmacokinetics|December 1, 2004
Pharmacokinetics of antiretrovirals in pregnant womenMark Mirochnick, Edmund Capparelli
Seminars in Fetal & Neonatal Medicine|February 11, 2005
Pharmacotherapy of perinatal HIVEdmund Capparelli, Natella Rakhmanina, Mark Mirochnick
Current Opinion in Pediatrics|March 12, 2009
Immunotherapy in neonatal sepsis: advances in treatment and prophylaxisMichael Cohen-Wolkowiez, Daniel K Benjamin, Edmund Capparelli
Cureus|February 2, 2019
Dosing Oncology Therapeutics in Combination Therapy for Renal Dysfunction: The University of California San Diego Study of Personalized Cancer Therapy to Determine Response and Toxicity (UCSD-PREDICT) ExperienceMina Nikanjam, Jason Wing, Edmund Capparelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2022
Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and AdolescentsElaine J Abrams, Edmund Capparelli, Theodore Ruel, et al.
Statistics in Biopharmaceutical Research|January 23, 2023
Simulation-Based Pharmacokinetics Sampling Design for Evaluating Correlates of Prevention Efficacy of Passive HIV Monoclonal Antibody ProphylaxisLily Zhang, Peter B Gilbert, Edmund Capparelli, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2019
Using Mycobacterium tuberculosis Single-Nucleotide Polymorphisms To Predict Fluoroquinolone Treatment ResponseMarva Seifert, Edmund Capparelli, Donald G Catanzaro, et al.
Plos Neglected Tropical Diseases|August 1, 2014
Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosisRosa M Andrade, Juan D Chaparro, Edmund Capparelli, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Population pharmacokinetics of cefepime in the neonateEdmund Capparelli, Christine Hochwald, Maynard Rasmussen, et al.
Clinical Therapeutics|May 19, 2009
Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover studyJaret Malloy, Edmund Capparelli, Michael Gottschalk, et al.
Pageof 9